Trial Profile

A pragmatic proof of concept study to evaluate the effect of dupilumab on mannitol challenge in severe asthma with type 2 inflammation

Status: Active, no longer recruiting

Phase of Trial: Phase III

Latest Information Update: 09 Feb 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Dupilumab (Primary)
Indications Asthma
Focus Proof of concept; Therapeutic Use
Acronyms DISA

Most Recent Events

06 Feb 2024 Status changed from recruiting to active, no longer recruiting.
05 May 2022 Recruitment completion is expected on 4 April 2024, according to ISRCTN: Current Controlled Trials
28 Apr 2022 New trial record

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com